EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With Influenza

Sara Bohnstedt Mørup, Maja Milojevic iD, Seyed Mahmood Taghavi Shahri, Brad T Sherman, Weizhong Chang, Ruth Lynfield, Marie Helleberg iD, Melissa Skeans, Lars Østergaard, Line Borgwardt, Norman Gerry, Marcelo Losso und 12 weitere

Immunity, Inflammation and Disease · 2026-03 · 14 (3)

DOI: 10.1002/iid3.70394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 11.03.2026. Verfasst von Sara Bohnstedt Mørup und 23 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Health, Immunity and Infections (CHIP) and INSIGHT Copenhagen ICC, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Influenza, Human, Polymorphism, Single Nucleotide. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish National Research Foundation, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Knowledge of the human genetic contribution to the risk of complications from influenza is limited. This study assessed the association between human single‐nucleotide polymorphisms (SNPs) and disease progression in individuals with influenza.

Methods

A targeted analysis of 10 SNPs with prior evidence in COVID‐19 and a genome‐wide association study (GWAS) were used to assess associations between SNPs and disease progression in two multinational cohorts with suspected or laboratory‐confirmed influenza: a hospitalized cohort ( n = 1634) and a pooled cohort of hospitalized and outpatients ( n = 3469). Disease progression was defined as prolonged hospitalization (> 28 days), progression to mechanical ventilation, admittance to intensive care unit, or death (for hospitalized individuals) or progression to hospitalization or death (for outpatients).

Results

Disease progression was observed in 9.1% of hospitalized patients and 2.2% of outpatients. Age was a significant risk factor for disease progression, with 20% increased odds of disease progression per 10‐year increase in age (OR: 1.20, 95%CI: 1.08–1.33, p < 0.001). Disease progression rates also differed by continent ( p < 0.0001). Targeted SNP analyses did not identify significant associations with disease progression; however, the strength of associations was most pronounced in sensitivity analyses for the pooled cohort in individuals < 65 years old. GWAS analyses did not identify significant common SNP associations in either the hospitalized or pooled cohorts, nor in sensitivity analysis of (1) individuals with laboratory‐confirmed influenza and (2) those aged < 65 years.

Conclusion

In a geographically diverse cohort of individuals with influenza, the genetic links to disease progression only started to become evident in the sensitivity analyses, mainly when looking at younger individuals. The power to detect associations was limited by the rate of disease progression and heterogeneity in phenotypes of the individuals studied, and therefore, additional studies focused on the role of genetics in influenza disease progression are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanPolymorphism, Single NucleotideHumansDisease ProgressionFemaleMaleMiddle AgedGenome-Wide Association StudyAdultAgedGenetic Predisposition to DiseaseRisk FactorsHospitalizationAdolescentSARS-CoV-2Young AdultCohort StudiesChild

Stichwörter der Autor:innen

GWASSNP‐microarrayhost geneticssevere influenzatargeted analyses

Autor:innen und Institutionen

  • Centre of Excellence for Health, Immunity and Infections (CHIP) and INSIGHT Copenhagen ICC, Copenhagen, Denmark.
  • Laboratory of Human Retrovirology and lmmunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Minnesota Department of Health, Saint Paul, Minnesota, USA.
  • Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Maja Milojevic, Marie Helleberg, Daniel D Murray

Förderung

  • Danish National Research Foundation
  • NIH HHS
  • NCI NIH HHS
  • NCI/NIAID
  • Subcontract
  • NIH
  • Danmarks Grundforskningsfond
  • National Institutes of Health

Zitieren

APA

Mørup, S. B., Milojevic, M., Shahri, S. M. T., Sherman, B. T., Chang, W., Lynfield, R., Helleberg, M., Skeans, M., Østergaard, L., Borgwardt, L., Gerry, N., Losso, M., Baillie, K., Davey, R., Dwyer, D. E., Phetsouphanh, C., Papastamopoulos, V., Novak, R. M., Murray, D. D., …, & INSIGHT FLU 002 Plus and FLU 003 Plus Study Groups (2026). Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With Influenza. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70394

Vancouver

Mørup SB, Milojevic M, Shahri SMT, Sherman BT, Chang W, Lynfield R, et al. Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With Influenza. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70394

BibTeX
@article{Mrup2026,
  author = {Mørup, Sara Bohnstedt and Milojevic, Maja and Shahri, Seyed Mahmood Taghavi and Sherman, Brad T and Chang, Weizhong and Lynfield, Ruth and Helleberg, Marie and Skeans, Melissa and Østergaard, Lars and Borgwardt, Line and Gerry, Norman and Losso, Marcelo and Baillie, Kenneth and Davey, Richard and Dwyer, Dominic E and Phetsouphanh, Chansavath and Papastamopoulos, Vasileios and Novak, Richard M and Murray, Daniel D and Reekie, Joanne and Lundgren, Jens D and Lane, H Clifford and Reilly, Cavan and INSIGHT FLU 002 Plus and FLU 003 Plus Study Groups, INSIGHT FLU 002 Plus and FLU 003 Plus Study Groups},
  title = {Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With Influenza},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/iid3.70394}
}
Kostenlos starten →